Sanofi plans new European industrial champion for active pharmaceutical ingredients (API)
- A new company(1) would ensure significant active pharmaceutical ingredient (API) manufacturing and supply capacity for patients in Europe and beyond.
- The new industry champion would rank 2(2) worldwide, with an estimated revenue of €1 billion in 2022.
- Headquarters would be in France. An IPO on E…








